Ignyta, Inc. Gains 69.73%
Mon, Apr 17, 2023 at 07:04 PM
Ignyta, Inc. (RXDX:NASDAQ) soared at $193.51, a gain of 69.7%. On Mon, Apr 17, 2023, RXDX:NASDAQ hit a New 2-Week High of $193.51. The stock got featured on our News Catalysts scanner on Mon, Apr 17, 2023 at 04:54 PM in the 'ACQUISITION' category. From Mon, Apr 03, 2023, the stock recorded 66.67% Up Days and 70.00% Green Days
About Ignyta, Inc. (RXDX:NASDAQ)
Ignyta Inc is a precision oncology biotechnology company. Its research is targeting tumor reduction and cancer treatment through both integrated therapeutic and companion diagnostics. It aims to develop and commercialize molecularly targeted therapies.
Top 10 Gainers:
- Presto Automation Inc Com (PRST:NASDAQ), 158.57%
- ContraFect Corporation (CFRX:NASDAQ), 154.44%
- Bellicum Pharmaceuticals, Inc. (BLCM:NASDAQ), 102.85%
- Ignyta, Inc. (RXDX:NASDAQ), 69.73%
- Satsuma Pharmaceuticals, Inc. (STSA:NASDAQ), 63.69%
- Versus Systems Inc. (VS:NASDAQ), 53.58%
- Charah Solutions, Inc. (CHRA:NYSE), 49.32%
- Toro Corp. (TORO:NASDAQ), 45.98%
- Gamida Cell Ltd. (GMDA:NASDAQ), 38.79%
- Charah Solutions Inc. 8.50% Senior Notes due 2026 (CHRB:NYSE), 38.18%